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Summary.-Macrophages have been isolated from ascitic and collagenase-dispersed
tumours from patients undergoing surgery for ovarian cancer. Macrophages were
present in varying proportions in both sites, though the ratio of macrophages to
tumour cells was higher in ascites. Marked variation in size (as detected by sedi-
mentation velocity) and cytochemical markers in the macrophages was noted.
Highly enriched macrophage fractions wereisolatedfromtheascitesandcollagenase-
dispersed solid tumours by a combination of sedimentation velocity and selective
EA RFC or adherence techniques. Suppressor activity in the PHA assay was detected
in tumour macrophages (4/10 giving>50% inhibition), ascitic macrophages (1/15)
and blood monocytes (2/7). Lymphocyte fractions from tumours were unresponsive
to PHA and failed to suppress the blood response. Suppressor activity was also
present in the purified tumour-cell fraction of 6/14 patients.
ADCC activity was tested in a few patients. When the activity was determined
against the SB target cells, tumour-derived macrophages were inactive, whereas
the ascitic fraction showed low but significant activity which averaged much lower
than patient blood values. The ADCC assays carried out with the CRC target cell
indicated activitywithinthe range ofpatient blood values in4/4ascites and2/4tumour
macrophage fractions.
Cytotoxicity was also assessed against co-purified autologous tumour cells.
Although activity was detected in many of the tests, the results seemed to reflect
target cell sensitivity. There appeared to be a correlation between cytotoxicity with
test macrophages and normal blood mononuclear cells.
The results indicate that the cytochemical heterogeneity and the variation in size
between macrophage fractions is associated with a spectrum of activities.
WE HAVE INITIATED a study ofimmune
competence of the various inflammatory
cell types infiltrating primary solid and
ascitic ovarian tumours. In the first paper
(Haskill et al., 1982a) we outlined the
methods used to isolate these cells and
characterized the cell markers associated
with infiltrating cells from these tumours.
Two classes were characterized; 1 sedi-
mented at < 6 mm/h and was similar in
size to most blood mononuclear cells;
the other was composed oflarger, strongly
adherent macrophages distinct from blood
monocytes, which sedimented with the
tumour cells. In the second communica-
tion (Haskill et al. 1982b) we investigated
effector-cell functions (PHA, ADCC and
NK) associated with blood and blood-
equivalent inflammatory cells present
in both ascitic and solid tumours. The
data indicated that all tumour-derived
effector-cell tests were markedly depres-S. HASKILL ET AL.
sed, whilst only the ascites effector cells
marked by FcR were depressed relative to
patient blood.
In the present report, we have assessed
some of the potential effector-cell activi-
ties associatedwiththe large macrophages.
Macrophages, distinguished from blood
monocytes on the basis of sedimentation
velocity, were isolated from both ascites
and solid tumours. The results indicate
that cytotoxicity, ADCC and suppressor-
cell tests can be detected in tumour-
derived macrophages, but there is marked
variation between patients.
MATERIALS AND METHODS
The 38 patients in this study have been
described earlier (Haskill et al., 1982a) as has
the general methodology.
Autologous tumour-cell cytotoxicity.-
Tumour-cell fractions were isolated from
either the nonadherent cells or the nonEA
RFC fraction obtained during isolation of
the macrophages in the >6 mm/h popula-
tions. Such tumour cells were only used if
>90% ofthe cells were obviously malignant,
as judged by nuclear and cytoplasmic
features. The assay was performed in 3040
MicroTest II culture plates (Falcon Plastics,
Osnard, Cal. U.S.A.). To 0-1 ml of various
effector-cell concentrations, 2 x 104 51Cr-label-
led target cells were added in 0-1 ml. Target
cells were also incubated without effector
cells to estimate the level of spontaneous
51Cr release. The plates were incubated at
370C in 5% C02 for 16 h, and were then
centrifuged at 500 g for 5 min. Aliquots
(0.1 ml) of the supernatant were removed
and placed in tubes, and the radioactivity
was measured in a gamma counter.
Calculation of cytotoxicity.-For autologous
cytotoxicity and ADCC assays, spontaneous
release (SR) was defined as the ct/min
released from targets incubated with medium
alone. Maximal release (MR) was determined
by measuring ct/min in the supernatants
after detergent lysis (1% Triton x 100) of
the various target cells. The formula used
to calculate the per cent specific release
was:
ct/min experimental-ct/min SR
ct/min MR -ct/min SR
Data were calculated and statistically analy-
sed by using a cytotoxicity program accord-
ing to the above formula with a PDP 11/20
computer (Digital Equipment Corp., May-
nard, Mass. U.S.A.).
RESULTS
Isolation and characterization ofascites and
tumour-derived macrophaqes
In Haskill et al. (1982a) we described
the technique for isolating macrophages
from both ascites and collagenase-disper-
sed ovarian tumours. Macrophages, dis-
tinct in size and therefore in sedimentation
velocity, were isolated for in vitro func-
tional and cytochemical assays. A sum-
mary ofthe average values for the various
markers used in Haskill et al. (1982a) is
given in Fig. 1. The results indicate that
on the basis of FcR, esterase and acid
phosphatase reactions, macrophage frac-
tions were usually 90% pure. Contamina-
tion was seldom due to tumour cells; the
remaining cells were usually polymorphs
or, occasionally, plasma cells. Ascitic
fluids frequently contained peroxidase-
positive macrophages (MPer) indicating
recently arrived monocytes. Weakly stain-
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FIG. 1.-Summary of macrophage cyto-
chemical data in Haskill et al. (1982a).
The results indicate that on the basis of
Fc receptors, nonspecific esterase (NSE)
and acid phosphatase (AP), ascites-
derived macrophage fractions averaged
90% macrophages. Tumour-derived mac-
rophage fractions were contaminated with
neutrophils and plasma cells. Tumour cells
did not exceed 5% of the population.
-1 I I I i
748INFLAMMATORY CELLS IN OVARIAN CANCER. III
40
36
32
28
24 Asc M#
o ~~~~~~~~~~~Tumour
Cells
Control ,,20 TmU
A,16
0)
E12
Tu M+1
4
0
0 5x103 104 2XIO4
EFFECTOR CELL NUMBER/CULTURE
FIG. 2.-Demonstration of the selective
immunosuppressive activity of the lower-
velocity macrophages (TuMo) isolated
from a primary ovarian tumour. For
sedimentation-velocity profile see Haskill
et al. (1982a, Fig. 3). The higher-velocity
macrophages (TuMe2) and the ascites
macrophages (AscMo) failed to suppress;
similarly the tumour cells and tumour-
associated lymphocytes (TuLymphs). The
response of the autologous non-adherent
blood lymphocytes in the same assay is
indicated by the control line.
ing cells were sometimes found in tumour-
derived material.
Suppression ofthe PHA response
As tumour-associated macrophages in
highly immunogenic animal tumours have
previously been shown to possess immuno-
suppressive activity (Holden et al., 1976)
it was of interest to investigate this
function in spontaneous human malig-
nancies.
Blood monocytes, ascites and tumour-
derived macrophages (TuM) were tested
for activity in the PHA response of
autologous nonadherent blood lympho-
cytes. For comparison tumour cells as
well as tumour-derived lymphocytes (TIL)
were used when available. Because the
various tumours and ascites fluids con-
tained widely differing numbers of macro-
phages and lymphocytes, it was impos-
sible to use every effector-cell type in
each experiment. However, in each case,
more than one cell type from the same
patient was used.
The results of a typical experiment in
which a variety of effector-cell popula-
tions were testsed is given in Fig. 2.
Graded doses of cells were added to 104
nonadherent patient blood lymphocytes.
Tumour cells, TIL (which are routinely
unresponsive to PHA; Haskill etal., 1982b)
ascites-derived macrophages (AscM) and
a population of TuM sedimenting as fast
as the AscM, failed to suppress the res-
ponse. However, the slower-sedimenting
population of TuM was effective.
Similar experiments were carried out
on 18 patients with two or more test
populations available. Blood monocyte
levels were often so low at time of surgery
that these assays were difficult to accumu-
late data from. The results (Fig. 3)
indicated that blood monocytes were
sometimes suppressive, as were a lower
proportion of AscM. (Suppression was
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FIG. 3.-Summary of the immunosuppres-
sive activity of blood, AscM and TuM, as
well as TIL and autologous tumour cells
on autologous blood-lymphocyte responses
to PHA. Data reported only at the 1:1
ratio, though 05:1 and 2:1 ratios were
also tested. Tumour-cell contamination
was insufficient to account for the sup-
pression found in some of the macrophage
experinents.
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arbitrarily set as a decrease in the specific
response >20%. The degree of suppres-
sion appeared to be highest with TuM,
though activity was found only in 4/10
cases. Tumour cells were frequently active
in this test. As reported in Haskill et al.
(1982b), TIL always failed to suppress
the response. The results indicate only
that there is a wide variation in supres-
sive activity within the various effector-
cell categories. No attempt was made to
establish significant differences between
groups, due to the wide variation ob-
served.
ADCC Activity ofAscM and TuM
ADCC assays were carried out against
either the K-cell sensitive tumour target
SB, or the monocyte-sensitive erythroid
CRBC target cell. Previously, we reported
that the blood mononuclear-cell fraction
of these patients is frequently as active
as that of normal donors in both these
assays (Haskill et al., 1982b). TuM had
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FIG. 4. Summary of the ADCC activity
associated with both ascites- and tumour-
derived macrophages. Target cells were
coated with TNP-anti-TNP. E: T cell
cell ratio was 20: 1 inthe SB assay and 3: 1
in the CRC assay.
TABLE.-Summary ofautologus cytoxicity data
Patient Effector-cell source
F.D. TuM
PB
NB
J.A. AscM
AscLymph
TuM
C.O. AscM
AscLymph
NB
D.A. AscM
TuM
NB
M.W. TuM
TuLymph
NB
S.C. AscM
AscLymph
NB
E.Mc. AscM
NB
S.B. AscM
AscLymph
NB
E.H. AscM
AscLymph
NB
L.F. AscM
TuM
L.H. AscM
AscLymph
15Cr
spontaneous release
40
35
19
28
40
50
42
23
29
32
30
% Specific release
10:1 3:1 1:1
7 9 18
27 20 8
17 9 10
25 30
0 0
4 3
0 0
6 5
12 8 3
12 32 26
14 25 16
12 23 18
0 0 2
11 9 7
6 5 1
4 5 0
7 5 8
6 5 5
29 23
1r, 14 10
0 0 0
0 0 0
0 0 0
8 18 22
23 17 12
26 18 9
0 0
1
0 0 0
0 0 0
I I I..
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significant activity in 2/4 cases against
the monocyte-sensitive CRBC target cell
(Fig. 4) while being inactive against the
K-cell-sensitive SB target cell. The AscM
were always active in the CRBC-TNP
assay (4/4) but showed generally lower
responses in the SB-TNP assay.
Macrophage fractions were tested for
cytotoxicity against autologous tumour
cells in a 20h 51Cr-release assay. Data
from the 11 patients in which spontaneous
isotope release did not exceed 50% are
given in the Table. The results indicate
cytotoxicity in many of the tests, usually
accompanied by similar activity with
both normal blood mononuclear cells
and the several TIL fractions used. The
low levels of activity the wide variation
between patients and the lack of clear-cut
differences between normal blood and
tumour-associated effector cells, pre-
cluded a more in-depth assessment of
these data.
DISCUSSION
Macrophages infiltrate a wide variety
of both animal and human tumours
(for general review, see Witz & Hanna,
1980; Haskill et al., 1978). Numerous
investigations have reported that direct
cytotoxicity is associated with macro-
phages isolated from highly immuno-
genic rodent tumours (Russell et al.,
1980; Herberman et al., 1980; Becker &
Haskill, 1980) and in at least 1 case, a
different type of activity (ADCC) was
found to be associated with these macro-
phages (Key & Haskill, 1981). Macro-
phages capable of suppressing mitogen
response have also been isolated from a
murine tumour (Holden et al., 1976). To
match this heterogeneity of function,
there was a similar degree ofheterogeneity
of cytochemical appearance and size in
both TuM from animal (Haskill, 1981)
and human tumours (Haskill et al., 1982a).
In few studies has heterogeneity of
macrophages been assessed or discussed
as an explanation, even partial, for the
heterogeneous responses detected with
the macrophages isolated from a variety of
animal or human tumours (Holden et al.,
1980; Haskill, 1981).
Functional activity of tumour-derived
effector cells had been difficult to docu-
ment for cells from human tumours. In
general, NK-cell function was markedly
depressed in human tumours (Vose et al.,
1977a; Totterman et al., 1980; Mantovani
et al., 1980a; Haskill et al., 1982b). Specifi-
cally cytotoxic T cells have only been
detected in a few instances (Vose et al.,
1977b; Werkmeister etal., 1979) suggesting
that effector-cell function may be difficult
to maintain in situ. Few investigators
have studied macrophage function in
human tumours. Vose (1978) reported
cytotoxicity against autologous tumour
cells in most TuM. However, the level of
cytotoxicity was similar to that of blood
monocytes or macrophages isolated from
tumour-free lung tissue. Mantovani et al.
(1980b) have reported on the activity of
macrophages in human ovarian ascites.
Ascitic macrophages were similar in acti-
vity to blood monocytes in a cytotoxi-
city assay against both a cell line and a
number of ovarian cell lines. Our present
studies only briefly touched upon auto-
logous cytotoxicity. The results indicated
low and variable levels of isotope release,
with little evidence of preferential host
activity.
In the present study, we have attempted
to assess some functions of macrophages
associated with both the tumour and the
ascites fluid. Because of the general
inactivity of all of the blood-equivalent
mononuclear cells associated with FcR
in both ascites and tumour sites (Haskill
et al., 1982b) it seemed important to
determine whether the FcR+ macrophages
were also depressed in activity in sup-
pressor and ADCC tests.
Immunosuppressive macrophages have
been associated with the spleens of a
variety of animal tumours displaying a
spectrum of immunogenicities (Kirchner,
1978; Parthenais & Haskill 1979; Farrar &
Elgert, 1978; Glaser et al., 1975). Peri-
pheral-blood monocytes of some cancer
patients have also been reported to be
751752 S. H:ASKILL ET AL.
immunosuppressive, and have been sug-
gested as one of the explanations for
depressed in vitro immune function in
these patients (Jerrells et al., 1978).
There has been only one report ofimmuno-
suppressive macrophages in situ (Holden
et at., 1976) and because this was a highly
immunogenic tumour, it seemed worth
investigating whether such effector cells
were present in spontaneous human
tumours.
Our present results indicate that macro-
phage suppressor-cell activity, previously
shown to be associated with TuM in the
highly immunogenic MSV model (Holden
et al., 1976) can also be detected in some
spontaneous human ovarian tumours.
While the relevance ofsuch an observation
is far from clear, it does indicate that
functionally active macrophages exist in
human tumours. Not all TuM were
immunosuppressive. Adequate cell num-
bers were not always available to carry
out ADCC assays in each of these sup-
pressor experiments, to determine whether
a lack of one activity was associated with
the presence of another. Neither was it
possible to collect enough data to deter-
mine whether activity in the tumour-
derived fraction was necessarily associated
with activity in the blood monocyte or
ascites fractions. The preliminary data
reported here do suggest that several
functionally distinct macrophage subsets
exist in situ. This is particularly obvious
when the sedimentation-velocity profiles
in Haskill et al. (1982a) are considered.
In particular the data in Fig. 2 demon-
strate that only 1 of 3 macrophage
fractions was immunosuppressive.
Ascitic macrophages were infrequently
active in the suppressor-cell assay, though
their activity in the ADCC/(CRC) assay
indicated that these cells were function-
ally active. In view ofthe heterogeneity of
macrophages in terms of sedimentation
velocity and cytochemical markers (Has-
kill et al., 1982a), the wide variation in
response was hardly surprising. Many
ascites-derived macrophage populations
were composed almost entirely of histio-
cyte-like macrophages, frequently con-
taining whole cells or cellular debris.
One can hardly expect cytolytic or
suppressor functions from such cells. At
the other extreme, a few ascitic fluids
contained mostly monocyte-like macro-
phages. We aim in subsequent investiga-
tions to assess whether the various
macrophage subsetsin ovarian cancerhave
distinct activities in autologous cytostasis
and cytotoxicity tests, both with and
without stimulation by biological modi-
fiers.
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